Is DSIP legal in Arizona?
status · caveats apply
9-aa peptide identified 1977; never advanced to NDA; PCAC under-review with vote scheduled July 24, 2026 (as 'Emideltide'). No state-level peptide restrictions beyond federal law in Arizona.
category: no approval · last verified May 13, 2026
§ 01
Quick answer
9-aa peptide identified 1977; never advanced to NDA; PCAC under-review with vote scheduled July 24, 2026 (as 'Emideltide'). No state-level peptide restrictions beyond federal law in Arizona.
§ 02
Full status breakdown
Federal status
FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: under pcac review
Do-not-compound list: under pcac review
Was Category 2; removed April 2026 administrative; now under formal PCAC review (as 'Emideltide'). Indications under review: opioid withdrawal, chronic insomnia, narcolepsy.
PCAC review history
- Jul 24, 2026 · pending · source ↗
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved; FDCA applies. July 2026 PCAC vote is the inflection point.
Personal possession: Not federally criminalized.
Arizona — state-specific
Sport-body status
WADA 2026
USADA
unknown
NCAA
unknown
What we couldn’t verify
§ 03
Also known as
DSIP is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
Delta Sleep Inducing PeptideEmideltideSchoenenberger-Monnier peptide9-aa sleep peptide
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch